Longwood Capital Partners as of Dec. 31, 2014
Portfolio Holdings for Longwood Capital Partners
Longwood Capital Partners holds 61 positions in its portfolio as reported in the December 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| iShares Russell 2000 Index (IWM) | 18.6 | $28M | 230k | 119.62 | |
| Amicus Therapeutics (FOLD) | 9.2 | $14M | 1.6M | 8.32 | |
| PowerShares QQQ Trust, Series 1 | 4.9 | $7.2M | 70k | 103.26 | |
| Alimera Sciences | 4.0 | $5.9M | 1.1M | 5.54 | |
| Pernix Therapeutics Holdings | 3.8 | $5.7M | 604k | 9.39 | |
| Biotelemetry | 3.3 | $4.9M | 484k | 10.03 | |
| Cempra | 3.2 | $4.8M | 205k | 23.51 | |
| Exelixis Inc cnv | 2.5 | $3.6M | 6.5M | 0.56 | |
| LeMaitre Vascular (LMAT) | 2.4 | $3.5M | 463k | 7.65 | |
| Cerus Corporation (CERS) | 2.1 | $3.2M | 508k | 6.24 | |
| Zafgen | 2.1 | $3.1M | 100k | 30.84 | |
| Tetraphase Pharmaceuticals | 2.0 | $3.0M | 75k | 39.70 | |
| Cti Biopharma | 2.0 | $2.9M | 1.2M | 2.36 | |
| Rrsat Global Comm Ntwrk | 1.9 | $2.9M | 401k | 7.20 | |
| Cardiome Pharma | 1.9 | $2.8M | 304k | 9.25 | |
| Volcano Corporation | 1.9 | $2.7M | 153k | 17.88 | |
| Ignyta | 1.7 | $2.5M | 369k | 6.85 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.6 | $2.4M | 20k | 118.80 | |
| Receptos | 1.6 | $2.3M | 19k | 122.50 | |
| Enanta Pharmaceuticals (ENTA) | 1.5 | $2.3M | 45k | 50.84 | |
| Horizon Pharma | 1.5 | $2.2M | 168k | 12.89 | |
| Vascular Solutions | 1.4 | $2.0M | 75k | 27.16 | |
| Orthofix International Nv Com Stk | 1.4 | $2.0M | 67k | 30.06 | |
| Build-A-Bear Workshop (BBW) | 1.2 | $1.8M | 89k | 20.10 | |
| IRIDEX Corporation (IRIX) | 1.2 | $1.8M | 209k | 8.60 | |
| eHealth (EHTH) | 1.2 | $1.7M | 70k | 24.91 | |
| Papa Murphys Hldgs | 1.1 | $1.6M | 141k | 11.62 | |
| Histogenics Corp Cmn | 1.0 | $1.5M | 137k | 11.00 | |
| DepoMed | 1.0 | $1.5M | 91k | 16.11 | |
| Hyperion Therapeutics | 1.0 | $1.5M | 61k | 24.00 | |
| Gw Pharmaceuticals Plc ads | 0.9 | $1.4M | 20k | 67.70 | |
| Kindred Biosciences | 0.9 | $1.3M | 172k | 7.45 | |
| Forward Pharma A/s | 0.8 | $1.3M | 61k | 20.83 | |
| Array Biopharma Inc note 3.000% 6/0 | 0.8 | $1.2M | 1.3M | 0.93 | |
| AMAG Pharmaceuticals | 0.8 | $1.1M | 27k | 42.64 | |
| Paratek Pharmaceuticals | 0.8 | $1.1M | 29k | 38.56 | |
| Combimatrix Corporation | 0.7 | $1.1M | 853k | 1.29 | |
| Horsehead Holding | 0.7 | $1.1M | 69k | 15.84 | |
| Agenus (AGEN) | 0.7 | $1.1M | 269k | 3.97 | |
| Bellicum Pharma | 0.7 | $1.1M | 46k | 23.04 | |
| Mol Global | 0.7 | $1.0M | 340k | 3.05 | |
| Cardica | 0.7 | $1.0M | 1.5M | 0.70 | |
| Heron Therapeutics (HRTX) | 0.7 | $1.0M | 101k | 10.06 | |
| Innocoll | 0.7 | $975k | 164k | 5.94 | |
| CAS Medical Systems | 0.6 | $862k | 523k | 1.65 | |
| Genvec | 0.5 | $738k | 355k | 2.08 | |
| athenahealth | 0.5 | $729k | 5.0k | 145.80 | |
| Neurocrine Biosciences (NBIX) | 0.5 | $704k | 32k | 22.35 | |
| NPS Pharmaceuticals | 0.4 | $644k | 18k | 35.75 | |
| Antares Pharma | 0.4 | $598k | 233k | 2.57 | |
| Sequenom | 0.4 | $574k | 155k | 3.70 | |
| Chembio Diagnostics | 0.4 | $571k | 146k | 3.91 | |
| Nanosphere | 0.4 | $568k | 1.5M | 0.39 | |
| pSivida | 0.3 | $503k | 122k | 4.11 | |
| Xencor (XNCR) | 0.2 | $353k | 22k | 16.04 | |
| Oxford Industries (OXM) | 0.2 | $337k | 25k | 13.62 | |
| Veracyte (VCYT) | 0.2 | $280k | 29k | 9.65 | |
| Insmed (INSM) | 0.1 | $203k | 13k | 15.43 | |
| Trillium Therapeutics, Inc. Cmn | 0.1 | $171k | 19k | 9.00 | |
| Community Health Sys Inc New right 01/27/2016 | 0.0 | $59k | 3.0M | 0.02 | |
| Assembly Biosciences | 0.0 | $30k | 3.8k | 7.89 |
